Zymergen locks in $400 mln Series C
Emeryville, California-based Zymergen, a molecular manufacturing technology company, has raised over $400 million in Series C funding. SoftBank Vision Fund led the round with participation from Goldman Sachs, Hanwha Asset Management, DCVC, True Ventures, Two Sigma Ventures, DFJ and Innovation Endeavors.
13 December 2018•1 min read
